132 related articles for article (PubMed ID: 37972755)
21. Exercise Improves V˙O2max and Body Composition in Androgen Deprivation Therapy-treated Prostate Cancer Patients.
Wall BA; GALVãO DA; Fatehee N; Taaffe DR; Spry N; Joseph D; Hebert JJ; Newton RU
Med Sci Sports Exerc; 2017 Aug; 49(8):1503-1510. PubMed ID: 28319589
[TBL] [Abstract][Full Text] [Related]
22. Effects of a multicomponent resistance-based exercise program with protein, vitamin D and calcium supplementation on cognition in men with prostate cancer treated with ADT: secondary analysis of a 12-month randomised controlled trial.
Mundell NL; Owen PJ; Dalla Via J; Macpherson H; Daly RM; Livingston PM; Rantalainen T; Foulkes S; Millar J; Murphy DG; Fraser SF
BMJ Open; 2022 Jun; 12(6):e060189. PubMed ID: 35750461
[TBL] [Abstract][Full Text] [Related]
23. Prostate Cancer Survivorship Essentials for men with prostate cancer on androgen deprivation therapy: protocol for a randomised controlled trial of a tele-based nurse-led survivorship care intervention (PCEssentials Hormone Therapy Study).
Green A; Newton RU; Smith DP; Tuffaha H; Galvão DA; Heathcote P; Patel MI; Christie D; Egger S; Sara SA; Heneka N; Chambers SK; Dunn J
BMJ Open; 2024 Mar; 14(3):e084412. PubMed ID: 38521521
[TBL] [Abstract][Full Text] [Related]
24. Nutrition therapy with high intensity interval training to improve prostate cancer-related fatigue in men on androgen deprivation therapy: a study protocol.
Baguley BJ; Skinner TL; Leveritt MD; Wright OR
BMC Cancer; 2017 Jan; 17(1):1. PubMed ID: 28049525
[TBL] [Abstract][Full Text] [Related]
25. Effects of a Group-Mediated Exercise and Dietary Intervention in the Treatment of Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: Results From the IDEA-P Trial.
Focht BC; Lucas AR; Grainger E; Simpson C; Fairman CM; Thomas-Ahner JM; Buell J; Monk JP; Mortazavi A; Clinton SK
Ann Behav Med; 2018 Apr; 52(5):412-428. PubMed ID: 29684136
[TBL] [Abstract][Full Text] [Related]
26. A pilot randomised controlled trial of a periodised resistance training and protein supplementation intervention in prostate cancer survivors on androgen deprivation therapy.
Kiwata JL; Dorff TB; Todd Schroeder E; Salem GJ; Lane CJ; Rice JC; Gross ME; Dieli-Conwright CM
BMJ Open; 2017 Jul; 7(7):e016910. PubMed ID: 28698349
[TBL] [Abstract][Full Text] [Related]
27. Effects of exercise on treatment-related adverse effects for patients with prostate cancer receiving androgen-deprivation therapy: a systematic review.
Gardner JR; Livingston PM; Fraser SF
J Clin Oncol; 2014 Feb; 32(4):335-46. PubMed ID: 24344218
[TBL] [Abstract][Full Text] [Related]
28. The Effect on Bone Outcomes of Home-based Exercise Intervention for Prostate Cancer Survivors Receiving Androgen Deprivation Therapy: A Pilot Randomized Controlled Trial.
Kim SH; Seong DH; Yoon SM; Choi YD; Choi E; Song Y; Song H
Cancer Nurs; 2018; 41(5):379-388. PubMed ID: 28731882
[TBL] [Abstract][Full Text] [Related]
29. A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer.
Newton RU; Taaffe DR; Spry N; Gardiner RA; Levin G; Wall B; Joseph D; Chambers SK; Galvão DA
BMC Cancer; 2009 Jun; 9():210. PubMed ID: 19563641
[TBL] [Abstract][Full Text] [Related]
30. Radiotherapy before or during androgen-deprivation therapy does not blunt the exercise-induced body composition protective effects in prostate cancer patients: A secondary analysis of two randomized controlled trials.
Newton RU; Mavropalias G; Fragala MS; Kraemer WJ; Häkkinen K; Taaffe DR; Spry N; Joseph D; Galvão DA
Exp Gerontol; 2021 Aug; 151():111427. PubMed ID: 34052346
[TBL] [Abstract][Full Text] [Related]
31. Time on androgen deprivation therapy and adaptations to exercise: secondary analysis from a 12-month randomized controlled trial in men with prostate cancer.
Taaffe DR; Buffart LM; Newton RU; Spry N; Denham J; Joseph D; Lamb D; Chambers SK; Galvão DA
BJU Int; 2018 Feb; 121(2):194-202. PubMed ID: 28872752
[TBL] [Abstract][Full Text] [Related]
32. Does exercise impact gut microbiota composition in men receiving androgen deprivation therapy for prostate cancer? A single-blinded, two-armed, randomised controlled trial.
Newton RU; Christophersen CT; Fairman CM; Hart NH; Taaffe DR; Broadhurst D; Devine A; Chee R; Tang CI; Spry N; Galvão DA
BMJ Open; 2019 Apr; 9(4):e024872. PubMed ID: 30987986
[TBL] [Abstract][Full Text] [Related]
33. Weight loss for overweight and obese patients with prostate cancer: a study protocol of a randomised trial comparing clinic-based versus Telehealth delivered EXercise and nutrition intervention (the TelEX trial).
Galvão DA; Taaffe DR; Hayne D; Lopez P; Lyons-Wall P; Tang CI; Chambers SK; Devine A; Spry N; Jeffery E; Kudiarasu C; Joseph D; Newton RU
BMJ Open; 2022 Jun; 12(6):e058899. PubMed ID: 35667725
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of walking exercise in promoting cognitive-psychosocial functions in men with prostate cancer receiving androgen deprivation therapy.
Lee CE; Kilgour A; Lau YK
BMC Cancer; 2012 Jul; 12():324. PubMed ID: 22846379
[TBL] [Abstract][Full Text] [Related]
35. A randomized controlled trial comparing changes in fitness with or without supervised exercise in patients initiated on enzalutamide and androgen deprivation therapy for non-metastatic castration-sensitive prostate cancer (EXTEND).
Harrison MR; Davis PG; Khouri MG; Bartlett DB; Gupta RT; Armstrong AJ; McNamara MA; Zhang T; Anand M; Onyenwoke K; Edwardson S; Craig D; Michalski M; Wu Y; Oyekunle T; Coyne B; Coburn A; Jones LW; George DJ
Prostate Cancer Prostatic Dis; 2022 Mar; 25(1):58-64. PubMed ID: 35273377
[TBL] [Abstract][Full Text] [Related]
36. The Effect of Exercise on Body Composition and Physical Performance in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy (ADT): A Narrative Synthesis.
Logan L; Toohey K; Kavanagh PS; Paterson C; McKune AJ
Semin Oncol Nurs; 2020 Oct; 36(5):151067. PubMed ID: 33010982
[TBL] [Abstract][Full Text] [Related]
37. A randomised controlled trial to evaluate the efficacy of a 6 month dietary and physical activity intervention for prostate cancer patients receiving androgen deprivation therapy.
Haseen F; Murray LJ; O'Neill RF; O'Sullivan JM; Cantwell MM
Trials; 2010 Aug; 11():86. PubMed ID: 20704726
[TBL] [Abstract][Full Text] [Related]
38. A randomized controlled trial of an exercise intervention targeting cardiovascular and metabolic risk factors for prostate cancer patients from the RADAR trial.
Galvão DA; Spry N; Taaffe DR; Denham J; Joseph D; Lamb DS; Levin G; Duchesne G; Newton RU
BMC Cancer; 2009 Dec; 9():419. PubMed ID: 19951446
[TBL] [Abstract][Full Text] [Related]
39. Exercise-induced attenuation of treatment side-effects in patients with newly diagnosed prostate cancer beginning androgen-deprivation therapy: a randomised controlled trial.
Ndjavera W; Orange ST; O'Doherty AF; Leicht AS; Rochester M; Mills R; Saxton JM
BJU Int; 2020 Jan; 125(1):28-37. PubMed ID: 31605663
[TBL] [Abstract][Full Text] [Related]
40. Intense Exercise for Survival among Men with Metastatic Castrate-Resistant Prostate Cancer (INTERVAL-GAP4): a multicentre, randomised, controlled phase III study protocol.
Newton RU; Kenfield SA; Hart NH; Chan JM; Courneya KS; Catto J; Finn SP; Greenwood R; Hughes DC; Mucci L; Plymate SR; Praet SFE; Guinan EM; Van Blarigan EL; Casey O; Buzza M; Gledhill S; Zhang L; Galvão DA; Ryan CJ; Saad F
BMJ Open; 2018 May; 8(5):e022899. PubMed ID: 29764892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
